{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"myopathy-due-to-calsequestrin-and-serca1-protein-overload","columns":[{"gene":"","key":"population-4abe8728ac7bd050db43","label":"Myopathy, vacuolar, with CASQ1 aggregates","mondoId":"MONDO:0014546","onsetQualifier":null,"originColumnKey":"MONDO:0014546/OMIM:616231","originalViews":[{"key":"MONDO:0014546/OMIM:616231","label":"Myopathy, vacuolar, with CASQ1 aggregates","scopeLabel":"OMIM:616231","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["324e3af7333d80af0749835f61fdc760baccf0c6741cb2268007e12414c1f49e","4388a58e83b64965ad39db7ef2c915da5242d3c5f778fd422190927fa8ff88db","6e8b4cf6e7dd4d55c00894be91656384083b5148df0c77cf79d804176786ded2","8c9bfa9d02423b7db9c1b955b0c7804153748be244a5dd97737b8ec23e2d3fda","c4e3e150402ddd236ad42d12368dcee0af17e5b32fda2eb0316a770344351301","d12dba3d811e5f9eb2a19258f160a0ad6aceaafa7bdf9827c73f0bfc42dd5f0c","d6c87ef7c6f909b43014dfee065aca432b11b4e2cff8962e1517ad65deb34b3b"],"recordQualifiers":{},"scopeLabel":"OMIM:616231","sourceIds":["OMIM:616231"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-858f2050a6d5c722fc86","label":"Vacuolar myopathy with sarcoplasmic reticulum protein aggregates","mondoId":"MONDO:0014546","onsetQualifier":null,"originColumnKey":"MONDO:0014546/ORPHA:88635","originalViews":[{"key":"MONDO:0014546/ORPHA:88635","label":"Vacuolar myopathy with sarcoplasmic reticulum protein aggregates","scopeLabel":"ORPHA:88635","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["77e495efc49cd92d37a79259b218e7762bbc342edc19b4fa8106bdd961bcb5cb","c643237a877d735ef3055d765a387d973404fe87507835c488f79d0459c01b23"],"recordQualifiers":{},"scopeLabel":"ORPHA:88635","sourceIds":["ORPHA:88635"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-4abe8728ac7bd050db43","population-858f2050a6d5c722fc86"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003388","HP:0003236","HP:0034940","HP:0003394","HP:0001324","HP:0003326","HP:0003198"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":9,"sourceGroups":{"omim":2,"orphanet":2,"published":5}},"features":[{"hpoId":"HP:0003388","label":"Easy fatigability","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0034940","label":"Muscle fiber calsequestrin 1-containing inclusion bodies","primary":true},{"hpoId":"HP:0003394","label":"Muscle spasm","primary":true},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":true},{"hpoId":"HP:0003326","label":"Myalgia","primary":true},{"hpoId":"HP:0003198","label":"Myopathy","primary":true},{"hpoId":"HP:0003701","label":"Proximal muscle weakness","primary":false}],"ledeHtml":"A rare, genetic vaculolar myopathy characterized by mild myopathy or elevated levels of creatine kinase in the blood without associated symptoms.","mondoId":"MONDO:0014546","node":{"canonicalSlug":"myopathy-due-to-calsequestrin-and-serca1-protein-overload","comparisons":[{"documentSha256":"e2e16e545d5530e5901387eda8ca3e18cb1d91b4a53c5d63d5c7693d6f9e676d","key":"legacy-myopathy-due-to-calsequestrin-and-serca1-protein-overload","kind":"legacy","label":"myopathy due to calsequestrin and SERCA1 protein overload","memberIds":["MONDO:0014546"],"mondoId":"MONDO:0014546","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/myopathy-due-to-calsequestrin-and-serca1-protein-overload.e2e16e545d5530e5901387eda8ca3e18cb1d91b4a53c5d63d5c7693d6f9e676d.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Myopathy due to calsequestrin and SERCA1 protein overload","originalSourceId":"ORPHA:88635","paragraphs":["A rare, genetic vaculolar myopathy characterized by mild myopathy or elevated levels of creatine kinase in the blood without associated symptoms."],"rawAttribution":"MONDO:0014546","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:01:29Z","upstream":"ORPHA:88635","url":"https://rarediseases.info.nih.gov/diseases/16770"},"ownColumnKeys":["population-4abe8728ac7bd050db43","population-858f2050a6d5c722fc86"],"publication":"published","relationships":[{"kind":"parent","label":"neuromuscular disease caused by qualitative or quantitative defects of protein SERCA1","mondoId":"MONDO:0016199","slug":null},{"kind":"parent","label":"hereditary neurological disease","mondoId":"MONDO:0100545","slug":null},{"kind":"parent","label":"hereditary skeletal muscle disorder","mondoId":"MONDO:0700223","slug":"hereditary-skeletal-muscle-disorder"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"324e3af7333d80af0749835f61fdc760baccf0c6741cb2268007e12414c1f49e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"1/10","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"PMID:26136523","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"4388a58e83b64965ad39db7ef2c915da5242d3c5f778fd422190927fa8ff88db","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003388","is_excluded":false,"label":"Easy fatigability","onset_id":null,"reference":"OMIM:616231","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"6e8b4cf6e7dd4d55c00894be91656384083b5148df0c77cf79d804176786ded2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0034940","is_excluded":false,"label":"Muscle fiber calsequestrin 1-containing inclusion bodies","onset_id":null,"reference":"PMID:30258016","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"77e495efc49cd92d37a79259b218e7762bbc342edc19b4fa8106bdd961bcb5cb","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:88635","disease_name":"Vacuolar myopathy with sarcoplasmic reticulum protein aggregates","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:88635","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"8c9bfa9d02423b7db9c1b955b0c7804153748be244a5dd97737b8ec23e2d3fda","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"OMIM:616231","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"c4e3e150402ddd236ad42d12368dcee0af17e5b32fda2eb0316a770344351301","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"3/10","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"PMID:26136523","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c643237a877d735ef3055d765a387d973404fe87507835c488f79d0459c01b23","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:88635","disease_name":"Vacuolar myopathy with sarcoplasmic reticulum protein aggregates","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:88635","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d12dba3d811e5f9eb2a19258f160a0ad6aceaafa7bdf9827c73f0bfc42dd5f0c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"4/10","hpo_id":"HP:0003394","is_excluded":false,"label":"Muscle spasm","onset_id":null,"reference":"PMID:26136523","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d6c87ef7c6f909b43014dfee065aca432b11b4e2cff8962e1517ad65deb34b3b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616231","disease_name":"Myopathy, vacuolar, with CASQ1 aggregates","evidence":"PCS","frequency_raw":"8/10","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:26136523","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16770\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014546\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:88635</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, genetic vaculolar myopathy characterized by mild myopathy or elevated levels of creatine kinase in the blood without associated symptoms.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16770\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"myopathy-due-to-calsequestrin-and-serca1-protein-overload","sourceDocuments":[{"name":"GARD: Myopathy due to calsequestrin and SERCA1 protein overload","reviewed":null,"source_release":"2026-10-21T17:01:29Z","url":"https://rarediseases.info.nih.gov/diseases/16770"},{"name":"MONDO: myopathy due to calsequestrin and SERCA1 protein overload","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014546"}],"sourceNote":"","synonyms":["myopathy, vacuolar, with CASQ1 aggregates","VMCQA"],"takeawayHtml":"","title":"myopathy due to calsequestrin and SERCA1 protein overload"},"schemaVersion":1}
